.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Cerilliant
Chinese Patent Office
Healthtrust
Teva
QuintilesIMS
Citi
Harvard Business School
Baxter
Mallinckrodt

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202832

« Back to Dashboard
NDA 202832 describes SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by B Braun, Baxter Hlthcare, Miles, Hospira, Taro, Fresenius Kabi Usa, Icu Medical Inc, Haemonetics, Abbott, Medefil Inc, Jubilant Hollistrstr, Laboratorios Grifols, Liebel-flarsheim, and Fresenius Medcl, and is included in twenty-six NDAs. It is available from seventeen suppliers. Additional details are available on the SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.

The generic ingredient in SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand three hundred and ninety-two drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.

Summary for NDA: 202832

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 202832

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM CHLORIDE 0.9%
sodium chloride
INJECTABLE;INJECTION 202832 NDA Medefil, Inc. 64253-202 64253-202-30 60 SYRINGE, PLASTIC in 1 BOX (64253-202-30) > 10 mL in 1 SYRINGE, PLASTIC
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
sodium chloride
INJECTABLE;INJECTION 202832 NDA Medefil, Inc. 64253-202 64253-202-30 60 SYRINGE, PLASTIC in 1 BOX (64253-202-30) > 10 mL in 1 SYRINGE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength9MG/ML (9MG/ML)
Approval Date:Jan 6, 2012TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength18MG/2ML (9MG/ML)
Approval Date:Jan 6, 2012TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength22.5MG/2.5ML (9MG/ML)
Approval Date:Jan 6, 2012TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Harvard Business School
Colorcon
Covington
AstraZeneca
Teva
US Department of Justice
Boehringer Ingelheim
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot